Answers are grounded in this paper and cite their sources.
Lariat-shaped lipopeptides are important antimicrobial agents; however, their complex structures pose synthetic challenges that hamper efficient structural diversification. Here we report a new chemoenzymatic approach that facilitates access to lariat-shaped macrocycles. Unprotected, branched peptides bearing multiple nucleophiles, including a native amino terminus and a pseudo-amino terminus, were site-selectively cyclized using versatile non-ribosomal peptide cyclases, generating an array of lariat peptides with diverse sequences and ring sizes. The generality of this strategy was demonstrated using two penicillin-binding protein-type thioesterases, SurE and WolJ, as well as one type-I thioesterase, TycC thioesterase. Furthermore, the remaining nucleophile, which was not involved in the cyclization process, was exploited as a reactive handle for subsequent diversification via a site-selective acylation reaction (that is, Ser/Thr ligation). The tandem cyclization–acylation strategy enabled the one-pot, modular synthesis of lariat-shaped lipopeptides equipped with various acyl groups. Biological screening revealed that the site-selective acylation endowed the macrocyclic scaffolds with antimycobacterial activity and led to the identification of lipopeptides that inhibit 50% of growth at concentrations of 8–16 µg ml−1. Non-ribosomal peptide cyclases that catalyse head-to-tail macrocyclization are repurposed here to enable regioselective macrocyclization of branched peptides with multiple nucleophiles, affording lariat-shaped peptides with various sequences and ring sizes. Coupled with subsequent site-selective acylation chemistry, this chemoenzymatic approach facilitates modular access to structurally diverse lariat lipopeptides.
No takes yet. Share an insight, caveat, or question.
Kobayashi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: